Adma Biologics, Inc.
ADMA· Nasdaq
Released May 11, 2022, after the close
10-Q filed May 11, 2022, 41 days after period end · 0001140361-22-018668
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $29.10M | $16.05M | $10.20M | $3.53M |
| Net Income | -$25.01M | -$18.38M | -$19.25M | -$13.07M |
| EPS Diluted |
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR
| -$0.13 |
| -$0.16 |
| -$0.26 |
| -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.